Company news
Korro Bio, Inc. news in 2019
Korro Bio, Inc.'s news releases, calls and decks from 2019, newest first.
Frequency Therapeutics Provides Business Updates and Reports Third Quarter 2019 Financial Results
November 17, 2019
Frequency Therapeutics Commences Dosing in its Phase 2a Study of FX-322 for Sensorineural Hearing Loss; FDA Grants FX-322 Fast Track Designation
October 9, 2019
Frequency Therapeutics Announces Pricing of Initial Public Offering
October 1, 2019